相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats
C. L. Limebeer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
N. L. Cluny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
Jeremy R. Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes
Keun-Hang Yang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior
P. A. Randall et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Δ9-Tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew
Andrew P. Ray et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism
Jonathan Z. Long et al.
CHEMISTRY & BIOLOGY (2009)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Jonathan Z. Long et al.
NATURE CHEMICAL BIOLOGY (2009)
The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew)
L. A. Parker et al.
PHYSIOLOGY & BEHAVIOR (2009)
The antiemetic interaction of Delta(9)-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew
Yaozhi Wang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus
Nina L. Cluny et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
Exposure to a context previously associated with nausea elicits conditioned gaping in rats: A model of anticipatory nausea
Cheryl L. Limebeer et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Anandamide effects on 5-HT3 receptors in vivo
Ildiko Racz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat
Erin M. Rock et al.
PSYCHOPHARMACOLOGY (2008)
Conditioned Nausea in Rats: Assessment by Conditioned Disgust Reactions, Rather Than Conditioned Taste Avoidance
Linda A. Parker et al.
CANADIAN JOURNAL OF EXPERIMENTAL PSYCHOLOGY-REVUE CANADIENNE DE PSYCHOLOGIE EXPERIMENTALE (2008)
A neutral CB1 receptor antagonist reduces weight gain in rat
Adam P. Chambers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret
K. A. Sharkey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting
Eyal Meiri et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat
Shelley K. Cross-Mellor et al.
PSYCHOPHARMACOLOGY (2007)
The effect of the 5-HT1A receptor agonist, 8-OH-DPAT, on motion-induced emesis in Suncus murinus
Farideh A. Javid et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Exposure to a lithium-paired context elicits gaping in rats: A model of anticipatory nausea
Cheryl L. Limebeer et al.
PHYSIOLOGY & BEHAVIOR (2006)
Prevention of nausea and vomiting following breast surgery
Rakhshanda Layeeque et al.
AMERICAN JOURNAL OF SURGERY (2006)
Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases
Paul L. R. Andrews et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2006)
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
F Pi-Sunyer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus:: An animal model of anticipatory nausea and vomiting
LA Parker et al.
PHYSIOLOGY & BEHAVIOR (2006)
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain
L. Cristino et al.
NEUROSCIENCE (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew
NA Darmani et al.
NEUROPHARMACOLOGY (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats
PJ McLaughlin et al.
PSYCHOPHARMACOLOGY (2005)
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597):: Effects on anandamide and oleoylethanolamide deactivation
D Fegley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Cannabinoids and cancer: causation, remediation, and palliation
W Hall et al.
LANCET ONCOLOGY (2005)
Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment
K Jordan et al.
EUROPEAN JOURNAL OF CANCER (2005)
Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis
NA Darmani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
5,7-dihydroxytryptamine lesions of the dorsal and median raphe nuclei interfere with lithium-induced conditioned gaping, but not conditioned taste avoidance, in rats
CL Limebeer et al.
BEHAVIORAL NEUROSCIENCE (2004)
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew)
M Kwiatkowska et al.
PSYCHOPHARMACOLOGY (2004)
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)
LA Parker et al.
PSYCHOPHARMACOLOGY (2004)
Endovanilloids - Putative endogenous ligands of transient receptor potential vanilloid 1 channels
M van der Stelt et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Δ9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets
MD Van Sickle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover
NA Darmani et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Conditioned taste aversion: modulation by 5-HT receptor activity and corticosterone
B Gorzalka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics - A University of Rochester James P. Wilmot Cancer Center community clinical oncology program study of 360 cancer patients treated in the community
JT Hickok et al.
CANCER (2003)
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists
PJ Hesketh et al.
EUROPEAN JOURNAL OF CANCER (2003)
Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats
LA Parker et al.
INTEGRATIVE PHYSIOLOGICAL AND BEHAVIORAL SCIENCE (2003)
Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea
LA Parker et al.
PSYCHOPHARMACOLOGY (2003)
The 5-HT1A agonist 8-OH-DPAT dose-dependently interferes with the establishment and the expression of lithium-induced conditioned rejection reactions in rats
CL Limebeer et al.
PSYCHOPHARMACOLOGY (2003)
Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response
H Hermann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis
MS Aapro et al.
ANNALS OF ONCOLOGY (2003)
Direct inhibition by cannabinoids of human 5-HT3A receptors:: probable involvement of an allosteric modulatory site
M Barann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Cannabidiol: An overview of some pharmacological aspects
R Mechoulam et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Control of nausea and vomiting after chemotherapy: what is the evidence?
N Bartlett et al.
INTERNAL MEDICINE JOURNAL (2002)
Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 - A randomized controlled trial
S Van Belle et al.
CANCER (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets
H Yamakuni et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats
LA Parker et al.
NEUROREPORT (2002)
Cocaine-induced suppression of saccharin intake: A model of drug-induced devaluation of natural rewards
PS Grigson et al.
BEHAVIORAL NEUROSCIENCE (2002)
Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain
H Hermann et al.
NEUROSCIENCE (2002)
The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by Delta(9)-tetrahydrocannabinol and other cannnabinoids
NA Darmani
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Central neurocircuitry associated with emesis
PJ Hornby
AMERICAN JOURNAL OF MEDICINE (2001)
Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis
H Tsukada et al.
EUROPEAN JOURNAL OF CANCER (2001)
Modulation of transmitter release via presynaptic cannabinoid receptors
E Schlicker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2
NA Darmani
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret
MD Van Sickle et al.
GASTROENTEROLOGY (2001)
Cannabinoids for control of chemotherapy induced nausea and vomiting:: quantitative systematic review
MR Tramèr et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Cannabinoids and the gastrointestinal tract
RG Pertwee
GUT (2001)
The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets
II Simoneau et al.
ANESTHESIOLOGY (2001)
Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew
NA Darmani
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Tetrahydrocannabinol (THC) interferes with conditioned retching in Suncus murinus:: An animal model of anticipatory nausea and vomiting (ANV)
LA Parker et al.
NEUROREPORT (2001)
Δ9-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist/inverse agonist SR 141716A
NA Darmani
NEUROPSYCHOPHARMACOLOGY (2001)
The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew
PLR Andrews et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
